Australian TGA Issues Clinical Requirement, Conformity Assessment Guidance
This article was originally published in The Gray Sheet
Executive Summary
Relevant postmarket data should be included in submissions to re-register devices under Australia's recently enacted medical device regulatory framework, according to a Therapeutic Goods Administration guidance on clinical evidence requirements